J&J Unit Rejected by U.S. High Court on Procrit Kickback Suit
This article is for subscribers only.
The U.S. Supreme Court rejected an appeal by a Johnson & Johnson unit, refusing to stop a lawsuit by a former sales representative who says the company gave doctors kickbacks for prescribing its Procrit anemia drug.
The suit, filed under a whistleblower law known as the U.S. False Claims Act, says that kickbacks paid by J&J’s Ortho Biotech Products unit led to inflated reimbursements under the federal Medicare program for the elderly and disabled.